ZA92275B - Use of nadh and nadph as energy substitutes - Google Patents

Use of nadh and nadph as energy substitutes

Info

Publication number
ZA92275B
ZA92275B ZA92275A ZA92275A ZA92275B ZA 92275 B ZA92275 B ZA 92275B ZA 92275 A ZA92275 A ZA 92275A ZA 92275 A ZA92275 A ZA 92275A ZA 92275 B ZA92275 B ZA 92275B
Authority
ZA
South Africa
Prior art keywords
nadh
nadph
reduced form
adenine dinucleotide
nicotinamide adenine
Prior art date
Application number
ZA92275A
Inventor
Jorg Birkmayer
Birkmayer Jorg
Walter Birkmayer
Birkmayer Walter
Original Assignee
Birkmayer Joerg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birkmayer Joerg filed Critical Birkmayer Joerg
Publication of ZA92275B publication Critical patent/ZA92275B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Use is described of nicotinamide adenine dinucleotide in its reduced form (NADH) and/or nicotinamide adenine dinucleotide phosphate in its reduced form (NADPH) and/or a physiologically tolerated salt of the same for energy substitution in humans or animals, as is a foodstuff or confectionary product for human consumption or a feedstuff for animal consumption having a content of the substances mentioned.
ZA92275A 1991-01-24 1992-01-14 Use of nadh and nadph as energy substitutes ZA92275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102240A DE4102240C1 (en) 1991-01-24 1991-01-24

Publications (1)

Publication Number Publication Date
ZA92275B true ZA92275B (en) 1992-12-30

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92275A ZA92275B (en) 1991-01-24 1992-01-14 Use of nadh and nadph as energy substitutes

Country Status (14)

Country Link
EP (1) EP0496479B1 (en)
JP (1) JP2533709B2 (en)
AT (1) ATE112664T1 (en)
AU (1) AU663479B2 (en)
BR (1) BR9200207A (en)
CA (1) CA2059510C (en)
DE (2) DE4102240C1 (en)
DK (1) DK0496479T3 (en)
ES (1) ES2061313T3 (en)
FI (1) FI920323A (en)
HU (1) HU9200213D0 (en)
IE (1) IE69861B1 (en)
NO (1) NO304672B1 (en)
ZA (1) ZA92275B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668114A (en) 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
IT1318565B1 (en) * 2000-06-09 2003-08-27 World Pharma Tech Ltd NADH OCTOCOSANOL EVITAMIN E PROENERGETIC FOOD SUPPLEMENT
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (en) * 2008-02-20 2011-02-10 Emag Holding Gmbh Method for grinding wavy workpieces
DE102014103443A1 (en) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Composition for use in the treatment of fatigue, lack of concentration, withdrawal symptoms, headaches and colds, in particular loss of power, hangover and fatigue
KR102306818B1 (en) * 2018-07-26 2021-09-30 오리진 바이오테크놀로지 가부시키가이샤 Functional eggs and their production method
DE202022000567U1 (en) 2022-03-06 2022-03-16 Penta Phi Eg Liposomal formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
IT1162938B (en) * 1983-08-26 1987-04-01 Dino Spisni COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS
JPS60126220A (en) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc Nucleic acid component composition
ES2007350A6 (en) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Food products enriched with nucleosides and/or nucleotides and preparation thereof.
DE58905201D1 (en) * 1988-03-01 1993-09-16 Birkmayer Walther AGENT FOR TREATING THE PARKINSON SYNDROME.
AT397201B (en) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr USE OF THE ENZYME COFACTOR NADPH IN THE PRODUCTION OF A MEDICINAL PRODUCT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668114A (en) 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension

Also Published As

Publication number Publication date
CA2059510C (en) 1997-06-10
JP2533709B2 (en) 1996-09-11
EP0496479B1 (en) 1994-10-12
FI920323A0 (en) 1992-01-24
NO304672B1 (en) 1999-02-01
ATE112664T1 (en) 1994-10-15
DE59200603D1 (en) 1994-11-17
BR9200207A (en) 1992-10-06
AU663479B2 (en) 1995-10-12
CA2059510A1 (en) 1992-07-25
ES2061313T3 (en) 1994-12-01
JPH05262652A (en) 1993-10-12
NO920315L (en) 1992-07-27
IE920198A1 (en) 1992-07-29
HU9200213D0 (en) 1992-04-28
AU1039292A (en) 1992-07-30
EP0496479A1 (en) 1992-07-29
FI920323A (en) 1992-07-25
IE69861B1 (en) 1996-10-16
DE4102240C1 (en) 1992-04-09
DK0496479T3 (en) 1995-04-18
NO920315D0 (en) 1992-01-23

Similar Documents

Publication Publication Date Title
AU9062291A (en) Formulation for treating silage
AU653992B2 (en) Novel benzo-fused lactams that promote the release of growth hormone
AU655462B2 (en) Use of hydrocolloids for formulating and processing of low fat water activity confectionery products and process
CA2054358A1 (en) High acid nutritional formulations
AU5609186A (en) Dietary products & uses comprising methylsulfonymethane
EP0455808A4 (en) Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
EP0239378A3 (en) Hydratable powders
ES2054697T3 (en) A HYGIENIC PRODUCT, PARTICULARLY FOR THE PRESERVATION OF A DOG'S DENTURE.
ZA92275B (en) Use of nadh and nadph as energy substitutes
NZ240011A (en) Oil-in-water emulsion nutritional composition: processes for production
Albrektsen et al. Ascorbyl palmitate as a dietary vitamin C source for rainbow trout (Salmo gairdneri)
MY106830A (en) Preparation of a cooked product having an improved preservation based on animal proteins.
AU5744286A (en) Potassium, sodium or calcium formate additive for inhibiting respiration of and promoting desiccation of crops
ES553196A0 (en) PROCEDURE FOR THE OBTAINING OF PROPIONIC ACID, AMMONIC SALT (2: 1), AND DERIVED PRODUCTS USABLE IN THE CONSERVATION OF FOOD FOR HUMAN AND ANIMAL CONSUMPTION
CA2124925A1 (en) Preparation of dietary fatty acid salt products
GB2016900A (en) Concentrated food product
AU4120589A (en) Supported lactic acid
Riopel et al. Coronary risk factor modification in children: smoking. A statement for physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association
DE69621238D1 (en) Production of a vegetable milk powder
CA2081348A1 (en) Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof
Annison Feed enzymes: the science of their use in wheat-based diets
HUT61895A (en) Process for producing pharmaceutical composition against cancer and aids
FR2387606A1 (en) Moist pet food contg. meat-like pieces - obtd. by coagulating blood with a gum and a liq. sauce
ES2143442A1 (en) Application of levamisole in the manufacture of dietary products for promoting growth in fish
HUT38807A (en) Flavoured synthetic crisp bone of high hardness